ATE406450T1 - Ein coumermycin/novobiocin-reguliertes genexpressionsystem - Google Patents

Ein coumermycin/novobiocin-reguliertes genexpressionsystem

Info

Publication number
ATE406450T1
ATE406450T1 AT04737796T AT04737796T ATE406450T1 AT E406450 T1 ATE406450 T1 AT E406450T1 AT 04737796 T AT04737796 T AT 04737796T AT 04737796 T AT04737796 T AT 04737796T AT E406450 T1 ATE406450 T1 AT E406450T1
Authority
AT
Austria
Prior art keywords
coumermycin
novobiocin
target gene
transactivator
gene expression
Prior art date
Application number
AT04737796T
Other languages
English (en)
Inventor
Hui-Fen Zhao
Shi-Hsiang Shen
Original Assignee
Ca Nat Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ca Nat Research Council filed Critical Ca Nat Research Council
Application granted granted Critical
Publication of ATE406450T1 publication Critical patent/ATE406450T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT04737796T 2003-06-10 2004-06-09 Ein coumermycin/novobiocin-reguliertes genexpressionsystem ATE406450T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47705503P 2003-06-10 2003-06-10

Publications (1)

Publication Number Publication Date
ATE406450T1 true ATE406450T1 (de) 2008-09-15

Family

ID=33511833

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04737796T ATE406450T1 (de) 2003-06-10 2004-06-09 Ein coumermycin/novobiocin-reguliertes genexpressionsystem

Country Status (8)

Country Link
US (2) US7838501B2 (de)
EP (1) EP1631671B1 (de)
JP (1) JP4719147B2 (de)
AT (1) ATE406450T1 (de)
AU (1) AU2004245598B2 (de)
CA (1) CA2523879C (de)
DE (1) DE602004016152D1 (de)
WO (1) WO2004108933A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE406450T1 (de) 2003-06-10 2008-09-15 Ca Nat Research Council Ein coumermycin/novobiocin-reguliertes genexpressionsystem
GB2404382B (en) 2003-07-28 2008-01-30 Oxitec Ltd Pest control
GB2443186A (en) 2006-10-25 2008-04-30 Oxitec Ltd Expression system for mediating alternative splicing
GB2500113A (en) 2012-03-05 2013-09-11 Oxitec Ltd Arthropod male germline gene expression system
GB201303932D0 (en) 2013-03-05 2013-04-17 Oxitec Ltd Muscle actin promoter
WO2015148683A1 (en) * 2014-03-26 2015-10-01 Tocagen Inc. A retroviral vector having immune-stimulating activity
GB2526867A (en) 2014-06-05 2015-12-09 Oxitec Ltd Gene expression system
WO2018029534A1 (en) 2016-08-12 2018-02-15 Oxitec Ltd. A self-limiting, sex-specific gene and methods of using
EP3293263A1 (de) * 2016-09-07 2018-03-14 Steinbeis Innovation gGmbH Induzierbare genexpression durch lineare at-reiche dna-fragmente in säugetierzellen und zugehörige verfahren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1064300A (en) * 1962-12-17 1967-04-05 Bristol Banyu Res Inst Ltd A new antibiotic coumermycin
US6187757B1 (en) * 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
EP1135461A4 (de) * 1998-12-02 2003-03-26 Univ Boston Gen-netzwerke zur kontrolle der genexpression
US6916846B2 (en) * 2000-05-12 2005-07-12 Merck & Co. Inc. Coumermycin analogs as chemical dimerizers of chimeric proteins
ATE406450T1 (de) 2003-06-10 2008-09-15 Ca Nat Research Council Ein coumermycin/novobiocin-reguliertes genexpressionsystem

Also Published As

Publication number Publication date
JP2006526991A (ja) 2006-11-30
US20070026486A1 (en) 2007-02-01
EP1631671A1 (de) 2006-03-08
AU2004245598B2 (en) 2009-01-08
US8377900B2 (en) 2013-02-19
US7838501B2 (en) 2010-11-23
DE602004016152D1 (de) 2008-10-09
WO2004108933A1 (en) 2004-12-16
EP1631671B1 (de) 2008-08-27
CA2523879C (en) 2013-03-19
JP4719147B2 (ja) 2011-07-06
AU2004245598A1 (en) 2004-12-16
CA2523879A1 (en) 2004-12-16
US20100249220A1 (en) 2010-09-30

Similar Documents

Publication Publication Date Title
ATE406450T1 (de) Ein coumermycin/novobiocin-reguliertes genexpressionsystem
Reardon et al. Molecular anatomy of the human excision nuclease assembled at sites of DNA damage
DK1534830T3 (da) In vito-peptid-ekspressionsbibliotek
RS54701B1 (en) PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUTION ROUTE PERMEABLE TO THE CELL
HK1110895A1 (en) Method for carrying out the selective evolution of proteins in vitro
EP1994142A4 (de) Verfahren und zusammensetzungen zur schnellen isolierung kleiner rna-moleküle
ES2195171T3 (es) Sistema de transposicion in vitro usando transposasa tn5 modificada.
ATE538199T1 (de) Ribosomenpräsentations- und mrna- präsentationsverfahren mit selektion hinsichtlich erhöhter stabilität des proteins
ATE544473T1 (de) Chimäre moleküle zur modulation der genexpression
EP1601766A4 (de) Verfahren zur bildung von artenvielfältigen fragmentierten genbänken und biologische regler, die daraus gelöst werden
BRPI0506148A (pt) preparação farmacêutica para o tratamento de choque
WO2020036654A3 (en) Highly knotted molecular topologies from single-stranded nucleic acids
ATE286140T1 (de) E. coli extrakt zur synthese von proteinen
WO2003076561A3 (en) Recombinase fusion protein with enhanced cellular uptake
WO2008139153A3 (en) Expression system
DK1255816T3 (da) Skræddersyede peptidsyntetaser, fremgangsmåde til deres fremstilling samt deres anvendelse
WO2004042345A3 (en) Bacterial small-molecule three-hybrid system
HN2010000718A (es) Proteina m de estreptococo, fragmentos inmunogenicos,acidos nucleicos y metodos de uso.
EP1530633B8 (de) Isolierung und klonierung von dna aus nicht kultivierten organismen
AU2003256566A1 (en) Methods to construct multimeric dna and polymeric protein sequences as direct fusions or with linkers
WO2017030659A3 (en) Molecular sensor selection
AU1351501A (en) Gene sequences identified by protein motif database searching
ATE512983T1 (de) Rezeptor für das tgr3-like protein
Haney et al. Identification of Hsp70 modulators through modeling of the substrate binding domain
WO2011015379A8 (en) Human hcv-interacting proteins and methods of use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties